David Young - 12 Oct 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Pres. Research & Development, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
12 Oct 2023
Net transactions value
+$45,030
Form type
4
Filing time
12 Oct 2023, 17:54:31 UTC
Previous filing
10 Oct 2023
Next filing
12 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $45,030 +155,277 +25% $0.2900 767,701 12 Oct 2023 Direct
holding PCSA Common Stock 619,677 12 Oct 2023 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 215,703 12 Oct 2023 By Family Entities
holding PCSA Common Stock 370,887 12 Oct 2023 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.